Almac Group leads key workshops at the upcoming Global Clinical Supplies Group Conference (GCSG) in Atlanta, GA

April 27, 2018

Souderton, PA, U.S., 27 April, 2018Almac Clinical Services, a member of the Almac Group, a global pharmaceutical contract development and manufacturing organisation, will lead multiple strategic workshops at the upcoming Global Clinical Supplies Group GCSG Conference held at Grand Hyatt Atlanta in Buckhead from April 29 – May 2.

The following sessions, led by senior leadership, are designed to deliver key insights and provide an opportunity for participants to learn more about the state of clinical trials:

  • Mark Rohlfing, Vice President of Operations and Natalie Balanovsky, JIT Manufacturing Solutions Manager, will present on conference day 2 at 10:05am and day 3 at 11:30am on, Just in Time Services, a Custom Solution for Clinical Supplies (WS1).
  • Paul O’Connor, Global Vice President of Quality, will participate in multiple workshops and a panel discussion referencing Brexit’s impact to clinical supply logistics, on conference day 1 at 10:15am and 2:55pm, day 2 at 1:40pm and day 3 at 11:30am.
  • Olive McCormick, Head of Quality & QP, will present on conference day 2 at 2:55pm, on the topic of Data Integrity in the Clinical Supply Chain.

Richard Segiel, Vice President of Business Development, applauded Almac’s involvement: “Adding exceptional value through education is imperative to Almac’s commitment to our clients. Our team looks forward to providing GCSG participants with new information and solutions for successfully navigating the challenges within the clinical supplies industry.”

Conference attendees will immerse themselves in networking with peers and key opinion leaders, have the opportunity to participate in Q&A sessions following presentations on a range of clinical supply subjects, and enjoy a relaxed and educational atmosphere. Inspired by the GCSG mission, the theme for this year’s event will be “Rooted in Knowledge and Branching out through Innovation.”

To meet with members of Almac’s leadership during the GCSG Annual Conference, sign-up here:

About Almac Group

‘Partnering to Advance Human Health’

The Almac Group is an established contract development and manufacturing organisation that provides an extensive range of integrated services to the pharmaceutical and biotech sectors globally. The services range from R&D, biomarker discovery development and commercialisation, API manufacture, formulation development, clinical trial supply, IXRS® technology (IVRS/IWRS) through to commercial-scale manufacture.

The international company is a privately owned organisation that has organically grown over almost 50 years and now employs close to 5600 highly skilled personnel. Almac is headquartered in Craigavon, Northern Ireland with operations in the UK, Ireland, across the US (Pennsylvania, North Carolina and California) and in Asia (Singapore and Tokyo).


Back to news